{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:52:17Z","timestamp":1793069537726,"version":"4.5.0"},"reference-count":212,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T00:00:00Z","timestamp":1580947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"DOI":"10.3389\/fnins.2020.00082","type":"journal-article","created":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T04:33:00Z","timestamp":1580963580000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":123,"title":["Cortical and Striatal Circuits in Huntington\u2019s Disease"],"prefix":"10.3389","volume":"14","author":[{"given":"Sonja","family":"Blumenstock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Dudanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,2,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1136\/jnnp-2017-317371","article-title":"Interrogating cortical function with transcranial magnetic stimulation: insights from neurodegenerative disease and stroke.","volume":"90","author":"Agarwal","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B2","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/0166-2236(89)90074-x","article-title":"The functional anatomy of basal ganglia disorders.","volume":"12","author":"Albin","year":"1989","journal-title":"Trends Neurosci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/0166-2236(90)90107-l","article-title":"Functional architecture of basal ganglia circuits: neural substrates of parallel processing.","volume":"13","author":"Alexander","year":"1990","journal-title":"Trends Neurosci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/39885","article-title":"Anterograde transport of brain-derived neurotrophic factor and its role in the brain.","volume":"389","author":"Altar","year":"1997","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1523\/JNEUROSCI.3539-10.2011","article-title":"Differential electrophysiological changes in striatal output neurons in Huntington\u2019s disease.","volume":"31","author":"Andr\u00e9","year":"","journal-title":"J. Neurosci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1755-5949.2010.00134.x","article-title":"Dopamine and glutamate in Huntington\u2019s disease: a balancing act: dopamine-glutamate balance in Huntington\u2019s disease.","volume":"16","author":"Andr\u00e9","year":"2010","journal-title":"CNS Neurosci. Ther."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fnsys.2011.00046","article-title":"Altered balance of activity in the striatal direct and indirect pathways in mouse models of Huntington\u2019s disease.","volume":"5","author":"Andr\u00e9","year":"","journal-title":"Front. Syst. Neurosci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1176\/appi.neuropsych.17020039","article-title":"Complex dynamics in the Basal Ganglia: health and disease beyond the motor system.","volume":"30","author":"Andres","year":"2018","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/jnr.10272","article-title":"Striatal neurochemical changes in transgenic models of Huntington\u2019s disease.","volume":"68","author":"Ariano","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.38744","article-title":"Metformin reverses early cortical network dysfunction and behavior changes in Huntington\u2019s disease.","volume":"7","author":"Arnoux","year":"2018","journal-title":"eLife"},{"key":"B11","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1097\/00005072-199704000-199704013","article-title":"Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT1) mRNA expression in Huntington\u2019s disease\u2013an in situ hybridization study.","volume":"56","author":"Arzberger","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.21616","article-title":"Early dysfunction and progressive degeneration of the subthalamic nucleus in mouse models of Huntington\u2019s disease.","volume":"5","author":"Atherton","year":"2016","journal-title":"eLife"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1021\/acschemneuro.7b00508","article-title":"Functional relevance of endocannabinoid-dependent synaptic plasticity in the central nervous system.","volume":"9","author":"Augustin","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/1467-9450.00238","article-title":"Dopamine and cognitive functioning: brain imaging findings in Huntington\u2019s disease and normal aging.","volume":"42","author":"B\u00e4ckman","year":"2001","journal-title":"Scand. J. Psychol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.neuron.2016.08.037","article-title":"Spatially compact neural clusters in the dorsal striatum encode locomotion relevant information.","volume":"92","author":"Barbera","year":"2016","journal-title":"Neuron"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1093\/brain\/awf180","article-title":"Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation.","volume":"125","author":"Behrens","year":"2002","journal-title":"Brain"},{"key":"B17","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.neuron.2004.08.035","article-title":"Oscillatory entrainment of striatal neurons in freely moving rats.","volume":"43","author":"Berke","year":"2004","journal-title":"Neuron"},{"key":"B18","doi-asserted-by":"publisher","first-page":"6809","DOI":"10.1073\/pnas.120166397","article-title":"Severe deficiencies in dopamine signaling in presymptomatic Huntington\u2019s disease mice.","volume":"97","author":"Bibb","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B19","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1146\/annurev.pa.20.040180.002533","article-title":"Chemical pathology of Huntington\u2019s disease.","volume":"20","author":"Bird","year":"1980","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.neuint.2007.06.031","article-title":"Symptom-related changes of endocannabinoid and palmitoylethanolamide levels in brain areas of R6\/2 mice, a transgenic model of Huntington\u2019s disease.","volume":"52","author":"Bisogno","year":"2008","journal-title":"Neurochem. Int."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1038\/cdd.2015.11","article-title":"The CB1 cannabinoid receptor signals striatal neuroprotection via a PI3K\/Akt\/mTORC1\/BDNF pathway.","volume":"22","author":"Bl\u00e1zquez","year":"2015","journal-title":"Cell Death Differ."},{"key":"B22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/brain\/awq278","article-title":"Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington\u2019s disease.","volume":"134","author":"Bl\u00e1zquez","year":"2011","journal-title":"Brain"},{"key":"B23","doi-asserted-by":"publisher","first-page":"22480","DOI":"10.1073\/pnas.0911503106","article-title":"Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms.","volume":"106","author":"Bradford","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/7854_2013_256","article-title":"Mouse models of Huntington\u2019s disease","author":"Brooks","year":"2013","journal-title":"Behavioral Neurobiology of Huntington\u2019s Disease and Parkinson\u2019s Disease"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2016.00317","article-title":"Corticostriatal dysfunction in Huntington\u2019s disease: the basics.","volume":"10","author":"Bunner","year":"2016","journal-title":"Front. Hum. Neurosci."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-43024-w","article-title":"Cortical circuit alterations precede motor impairments in Huntington\u2019s disease mice.","volume":"9","author":"Burgold","year":"2019","journal-title":"Sci. Rep."},{"key":"B27","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nrn3241","article-title":"The origin of extracellular fields and currents \u2014 EEG. ECoG, LFP and spikes.","volume":"13","author":"Buzs\u00e1ki","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fnsys.2011.00061","article-title":"In vivo dopamine efflux is decreased in striatum of both fragment (R6\/2) and full-length (YAC128) transgenic mouse models of Huntington\u2019s disease.","volume":"5","author":"Callahan","year":"2011","journal-title":"Front. Syst. Neurosci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.nbd.2015.03.006","article-title":"Age-dependent alterations in the cortical entrainment of subthalamic nucleus neurons in the YAC128 mouse model of Huntington\u2019s disease.","volume":"78","author":"Callahan","year":"","journal-title":"Neurobiol. Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"3727","DOI":"10.1113\/JP270268","article-title":"Relationship between subthalamic nucleus neuronal activity and electrocorticogram is altered in the R6\/2 mouse model of Huntington\u2019s disease.","volume":"593","author":"Callahan","year":"","journal-title":"J. Physiol."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.104607","article-title":"Sex-dependent impaired locomotion and motor coordination in the HdhQ200\/200 mouse model of Huntington\u2019s disease.","volume":"132","author":"Cao","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.conb.2019.09.008","article-title":"Functional flexibility in cortical circuits.","volume":"58","author":"Cardin","year":"2019","journal-title":"Curr. Opin. Neurobiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/j.biopsych.2005.03.008","article-title":"Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6\/2 Huntington\u2019s disease mice.","volume":"57","author":"Centonze","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1042\/AN20090058","article-title":"Genetic mouse models of Huntington\u2019s disease: focus on electrophysiological mechanisms.","volume":"2","author":"Cepeda","year":"2010","journal-title":"ASN Neuro"},{"key":"B35","doi-asserted-by":"publisher","first-page":"7393","DOI":"10.1523\/JNEUROSCI.2137-12.2013","article-title":"Multiple sources of striatal inhibition are differentially affected in Huntington\u2019s disease mouse models.","volume":"33","author":"Cepeda","year":"2013","journal-title":"J. Neurosci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1523\/JNEUROSCI.23-03-00961.2003","article-title":"Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington\u2019s disease.","volume":"23","author":"Cepeda","year":"2003","journal-title":"J. Neurosci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1002\/jnr.20344","article-title":"Increased GABAergic function in mouse models of Huntington\u2019s disease: reversal by BDNF.","volume":"78","author":"Cepeda","year":"2004","journal-title":"J. Neurosci. Res."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2017.11.033","article-title":"Distinct inhibitory circuits orchestrate cortical beta and gamma band oscillations.","volume":"96","author":"Chen","year":"2017","journal-title":"Neuron"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2013.00114","article-title":"Dopamine imbalance in Huntington\u2019s disease: a mechanism for the lack of behavioral flexibility.","volume":"7","author":"Chen","year":"2013","journal-title":"Front. Neurosci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"8257","DOI":"10.1073\/pnas.1400988111","article-title":"A restricted population of CB1 cannabinoid receptors with neuroprotective activity.","volume":"111","author":"Chiarlone","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0089995","article-title":"Autaptic connections and synaptic depression constrain and promote gamma oscillations.","volume":"9","author":"Connelly","year":"2014","journal-title":"PLoS One"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1038\/s41386-018-0107-108","article-title":"Inhibition of endocannabinoid degradation rectifies motivational and dopaminergic deficits in the Q175 mouse model of Huntington\u2019s disease.","volume":"43","author":"Covey","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"4993","DOI":"10.1523\/JNEUROSCI.0135-16.2016","article-title":"Compromised dopaminergic encoding of reward accompanying suppressed willingness to overcome high effort costs is a prominent prodromal characteristic of the Q175 mouse model of Huntington\u2019s disease.","volume":"36","author":"Covey","year":"2016","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nature11846","article-title":"Concurrent activation of striatal direct and indirect pathways during action initiation.","volume":"494","author":"Cui","year":"2013","journal-title":"Nature"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1113\/JP270324","article-title":"Endocannabinoids mediate bidirectional striatal spike-timing-dependent plasticity.","volume":"593","author":"Cui","year":"2015","journal-title":"J. Physiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"10371","DOI":"10.1523\/JNEUROSCI.1592-09.2009","article-title":"Alterations in cortical excitation and inhibition in genetic mouse models of Huntington\u2019s disease.","volume":"29","author":"Cummings","year":"2009","journal-title":"J. Neurosci."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1042\/AN20100007","article-title":"Alterations in striatal synaptic transmission are consistent across genetic mouse models of Huntington\u2019s disease.","volume":"2","author":"Cummings","year":"2010","journal-title":"ASN Neuro"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1093\/hmg\/ddl224","article-title":"Aberrant cortical synaptic plasticity and dopaminergic dysfunction in a mouse model of huntington\u2019s disease.","volume":"15","author":"Cummings","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2015.00361","article-title":"Cognitive training at a young age attenuates deficits in the zQ175 mouse model of HD.","volume":"9","author":"Curtin","year":"2015","journal-title":"Front. Behav. Neurosci."},{"key":"B50","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1159\/000322540","article-title":"Impaired long-term potentiation in the prefrontal cortex of Huntington\u2019s disease mouse models: rescue by D1 dopamine receptor activation.","volume":"8","author":"Dall\u00e9rac","year":"2011","journal-title":"Neurodegener. Dis."},{"key":"B51","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nrn3444","article-title":"New insights into the classification and nomenclature of cortical GABAergic interneurons.","volume":"14","author":"Defelipe","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000419","article-title":"Strong preference for autaptic self-connectivity of neocortical PV interneurons facilitates their tuning to \u03b3-oscillations.","volume":"17","author":"Deleuze","year":"2019","journal-title":"PLoS Biol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jchemneu.2004.02.005","article-title":"Differential loss of striatal projection systems in Huntington\u2019s disease: a quantitative immunohistochemical study.","volume":"27","author":"Deng","year":"2004","journal-title":"J. Chem. Neuroanat."},{"key":"B54","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.nbd.2013.08.009","article-title":"Loss of corticostriatal and thalamostriatal synaptic terminals precedes striatal projection neuron pathology in heterozygous Q140 Huntington\u2019s disease mice.","volume":"60","author":"Deng","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fnsys.2014.00198","article-title":"Differential loss of thalamostriatal and corticostriatal input to striatal projection neuron types prior to overt motor symptoms in the Q140 knock-in mouse model of Huntington\u2019s disease.","volume":"8","author":"Deng","year":"2014","journal-title":"Front. Syst. Neurosci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/S0306-4522(00)00157-153","article-title":"Cannabinoid receptor messenger RNA levels decrease in a subset of neurons of the lateral striatum, cortex and hippocampus of transgenic Huntington\u2019s disease mice.","volume":"98","author":"Denovan-Wright","year":"2000","journal-title":"Neuroscience"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaw8546","article-title":"Astrocyte molecular signatures in Huntington\u2019s disease.","volume":"11","author":"Diaz-Castro","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/0166-2236(90)90111-m","article-title":"Excitotoxic injury of the neostriatum: a model for Huntington\u2019s disease.","volume":"13","author":"DiFiglia","year":"1990","journal-title":"Trends Neurosci."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1093\/cercor\/bhz245","article-title":"Cortical network dynamics is altered in mouse models of Huntington\u2019s disease.","author":"Donzis","year":"2019","journal-title":"Cereb. Cortex"},{"key":"B60","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.nbd.2013.10.002","article-title":"Hyperactivity and cortical disinhibition in mice with restricted expression of mutant huntingtin to parvalbumin-positive cells.","volume":"62","author":"Dougherty","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"B61","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.neuroscience.2009.06.014","article-title":"Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington\u2019s disease.","volume":"163","author":"Dowie","year":"2009","journal-title":"Neuroscience"},{"key":"B62","doi-asserted-by":"publisher","first-page":"4959","DOI":"10.1523\/JNEUROSCI.0316-16.2016","article-title":"Functional indicators of glutamate transport in single striatal astrocytes and the influence of Kir4.1 in normal and Huntington Mice.","volume":"36","author":"Dvorzhak","year":"2016","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"B63","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2217\/nmt.11.45","article-title":"Depression in the early stages of Huntington disease.","volume":"1","author":"Epping","year":"2011","journal-title":"Neurodegener. Dis. Manag."},{"key":"B64","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.baga.2012.04.029","article-title":"Corticostriatal dysfunction and glutamate transporter 1 (GLT1) in Huntington\u2019s disease: interactions between neurons and astrocytes.","volume":"2","author":"Estrada-S\u00e1nchez","year":"2012","journal-title":"Basal Ganglia"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fncir.2013.00019","article-title":"Role of cerebral cortex in the neuropathology of Huntington\u2019s disease.","volume":"7","author":"Estrada-S\u00e1nchez","year":"2013","journal-title":"Front. Neural Circuits"},{"key":"B66","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1093\/hmg\/ddq212","article-title":"In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington\u2019s disease subjects.","volume":"19","author":"Faideau","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"B67","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/S0169-328X(00)00062-60","article-title":"N-myc and c-myc expression in Alzheimer disease, Huntington disease and Parkinson disease.","volume":"77","author":"Ferrer","year":"2000","journal-title":"Mol. Brain Res."},{"key":"B68","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3233\/JHD-2012-120009","article-title":"Functional differences between direct and indirect striatal output pathways in Huntington\u2019s disease.","volume":"1","author":"Galvan","year":"2012","journal-title":"J. Huntingt. Dis."},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2015.00025","article-title":"Modulation of the glutamatergic transmission by Dopamine: a focus on Parkinson, Huntington and Addiction diseases.","volume":"9","author":"Gardoni","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"B70","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-neuro-061010-113641","article-title":"Modulation of striatal projection systems by dopamine.","volume":"34","author":"Gerfen","year":"2011","journal-title":"Annu. Rev. Neurosci."},{"key":"B71","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1111\/j.1460-9568.2009.06649.x","article-title":"Phosphodiesterase type IV inhibition prevents sequestration of CREB binding protein, protects striatal parvalbumin interneurons and rescues motor deficits in the R6\/2 mouse model of Huntington\u2019s disease.","volume":"29","author":"Giamp\u00e0","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"B72","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41593-019-0350-352","article-title":"Cerebral organoids at the air-liquid interface generate diverse nerve tracts with functional output.","volume":"22","author":"Giandomenico","year":"2019","journal-title":"Nat. Neurosci."},{"key":"B73","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/j.1460-9568.2006.04590.x","article-title":"Reduced expression of the TrkB receptor in Huntington\u2019s disease mouse models and in human brain.","volume":"23","author":"Gin\u00e9s","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"B74","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.tins.2012.06.008","article-title":"Striatal microcircuitry and movement disorders.","volume":"35","author":"Gittis","year":"2012","journal-title":"Trends Neurosci."},{"key":"B75","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0306-4522(00)00008-7","article-title":"The pattern of neurodegeneration in Huntington\u2019s disease: a comparative study of cannabinoid, dopamine, adenosine and GABAA receptor alterations in the human basal ganglia in Huntington\u2019s disease.","volume":"97","author":"Glass","year":"2000","journal-title":"Neuroscience"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.celrep.2016.06.059","article-title":"Cellular Taxonomy of the Mouse Striatum as Revealed by Single-Cell RNA-Seq.","volume":"16","author":"Gokce","year":"2016","journal-title":"Cell Rep."},{"key":"B77","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nrn.2016.57","article-title":"Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression.","volume":"17","author":"Grace","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"B78","doi-asserted-by":"publisher","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","article-title":"Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice.","volume":"28","author":"Gray","year":"2008","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.neuron.2016.04.043","article-title":"Endocannabinoid modulation of orbitostriatal circuits gates habit formation.","volume":"90","author":"Gremel","year":"2016","journal-title":"Neuron"},{"key":"B80","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41593-019-0341-343","article-title":"Unique contributions of parvalbumin and cholinergic interneurons in organizing striatal networks during movement.","volume":"22","author":"Gritton","year":"2019","journal-title":"Nat. Neurosci."},{"key":"B81","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1155\/NP.2003.107","article-title":"The Basal Ganglia and motor control.","volume":"10","author":"Groenewegen","year":"2003","journal-title":"Neural Plast."},{"key":"B82","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.neuron.2005.03.025","article-title":"Pathological Cell-Cell interactions elicited by a neuropathogenic form of mutant Huntingtin contribute to cortical pathogenesis in HD Mice.","volume":"46","author":"Gu","year":"2005","journal-title":"Neuron"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1002\/mds.25159","article-title":"Striatal neuronal loss correlates with clinical motor impairment in Huntington\u2019s disease.","volume":"27","author":"Guo","year":"2012","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"B84","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1006\/exnr.1998.6919","article-title":"Regional specificity of brain atrophy in Huntington\u2019s disease.","volume":"154","author":"Halliday","year":"1998","journal-title":"Exp. Neurol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nn.4532","article-title":"Developmental alterations in Huntington\u2019s disease neural cells and pharmacological rescue in cells and mice.","volume":"20","year":"2017","journal-title":"Nat. Neurosci."},{"key":"B86","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/00005072-199501000-199501013","article-title":"Early loss of neostriatal striosome neurons in Huntington\u2019s disease.","volume":"54","author":"Hedreen","year":"1995","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1016\/j.celrep.2017.10.097","article-title":"Spatiotemporal proteomic profiling of Huntington\u2019s disease inclusions reveals widespread loss of protein function.","volume":"21","author":"Hosp","year":"2017","journal-title":"Cell Rep."},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050717","article-title":"Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington\u2019s disease.","volume":"7","author":"Heikkinen","year":"2012","journal-title":"PLoS One"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3389\/neuro.07.006.2007","article-title":"Endocannabinoid signaling is critical for habit formation.","volume":"1","author":"Hil\u00e1rio","year":"2007","journal-title":"Front. Integr. Neurosci."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/nn.4332","article-title":"The mouse cortico-striatal projectome.","volume":"19","author":"Hintiryan","year":"2016","journal-title":"Nat. Neurosci."},{"key":"B91","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/s0896-6273(00)80764-80763","article-title":"A YAC mouse model for Huntington\u2019s disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration.","volume":"23","author":"Hodgson","year":"1999","journal-title":"Neuron"},{"key":"B92","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/ejn.14283","article-title":"Striatal GABAergic interneuron dysfunction in the Q175 mouse model of Huntington\u2019s disease.","volume":"49","author":"Holley","year":"","journal-title":"Eur. J. Neurosci."},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3389\/fnsyn.2019.00014","article-title":"Major contribution of somatostatin-expressing interneurons and cannabinoid receptors to increased GABA synaptic activity in the striatum of Huntington\u2019s disease mice.","volume":"11","author":"Holley","year":"","journal-title":"Front. Synaptic Neurosci."},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1523\/ENEURO.0008-14.2015","article-title":"Enhanced GABAergic inputs contribute to functional alterations of cholinergic interneurons in the R6\/2 mouse model of Huntington\u2019s disease.","volume":"2","author":"Holley","year":"2015","journal-title":"eNeuro"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0047026","article-title":"Dysfunctional behavioral modulation of corticostriatal communication in the R6\/2 mouse model of Huntington\u2019s disease.","volume":"7","author":"Hong","year":"2012","journal-title":"PLoS One"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3389\/fnsys.2012.00077","article-title":"Biological sources of inflexibility in brain and behavior with aging and neurodegenerative diseases.","volume":"6","author":"Hong","year":"2012","journal-title":"Front. Syst. Neurosci."},{"key":"B97","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/ejn.12045","article-title":"Downregulation of cannabinoid receptor 1 from neuropeptide Y interneurons in the basal ganglia of patients with Huntington\u2019s disease and mouse models.","volume":"37","author":"Horne","year":"2013","journal-title":"Eur. J. Neurosci."},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.180165","article-title":"Insights into GABAAergic system alteration in Huntington\u2019s disease.","volume":"8","author":"Hsu","year":"2018","journal-title":"Open Biol."},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1126\/science.1255263","article-title":"Fast-spiking, parvalbumin+ GABAergic interneurons: from cellular design to microcircuit function.","volume":"345","author":"Hu","year":"2014","journal-title":"Science"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.neuron.2014.08.041","article-title":"Toward a genetic dissection of cortical circuits in the mouse.","volume":"83","author":"Huang","year":"2014","journal-title":"Neuron"},{"key":"B101","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1111\/j.1469-7793.2001.0731e.x","article-title":"Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons.","volume":"532","author":"Huang","year":"2001","journal-title":"J. Physiol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1152\/jn.01056.2014","article-title":"Altered excitatory and inhibitory inputs to striatal medium-sized spiny neurons and cortical pyramidal neurons in the Q175 mouse model of Huntington\u2019s disease.","volume":"113","author":"Indersmitten","year":"2015","journal-title":"J. Neurophysiol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.1523\/JNEUROSCI.3693-15.2016","article-title":"Dysfunctional calcium and glutamate signaling in striatal astrocytes from Huntington\u2019s disease model mice.","volume":"36","author":"Jiang","year":"2016","journal-title":"J. Neurosci."},{"key":"B104","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/j.1471-4159.2006.03762.x","article-title":"Dopamine release is severely compromised in the R6\/2 mouse model of Huntington\u2019s disease.","volume":"97","author":"Johnson","year":"2006","journal-title":"J. Neurochem."},{"key":"B105","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1523\/JNEUROSCI.5687-08.2009","article-title":"Age-Dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington disease.","volume":"29","author":"Joshi","year":"2009","journal-title":"J. Neurosci."},{"key":"B106","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.tins.2017.05.002","article-title":"Unravelling and exploiting astrocyte dysfunction in Huntington\u2019s disease.","volume":"40","author":"Khakh","year":"2017","journal-title":"Trends Neurosci."},{"key":"B107","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/ana.24162","article-title":"Cortical interneuron loss and symptom heterogeneity in Huntington disease: interneuron Loss in HD cortex.","volume":"75","author":"Kim","year":"2014","journal-title":"Ann. Neurol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"3594","DOI":"10.1523\/JNEUROSCI.19-09-03594.1999","article-title":"Striatal neuronal activity and responsiveness to dopamine and glutamate after selective blockade of D1 and D2 dopamine receptors in freely moving rats.","volume":"19","author":"Kiyatkin","year":"1999","journal-title":"J. Neurosci."},{"key":"B109","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1152\/jn.2001.86.6.2667","article-title":"Electrophysiological and morphological changes in striatal spiny neurons in R6\/2 Huntington\u2019s disease transgenic mice.","volume":"86","author":"Klapstein","year":"2001","journal-title":"J. Neurophysiol."},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2017.08.015","article-title":"The spatiotemporal organization of the striatum encodes action space.","volume":"95","author":"Klaus","year":"2017","journal-title":"Neuron"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1002\/jnr.24495","article-title":"Dysfunctional striatal dopamine signaling in Huntington\u2019s disease.","volume":"97","author":"Koch","year":"2019","journal-title":"J. Neurosci. Res."},{"key":"B112","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.nbd.2015.11.020","article-title":"Differential changes in thalamic and cortical excitatory synapses onto striatal spiny projection neurons in a Huntington disease mouse model.","volume":"86","author":"Kolodziejczyk","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"B113","doi-asserted-by":"publisher","first-page":"9112","DOI":"10.1523\/JNEUROSCI.21-23-09112.2001","article-title":"Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington\u2019s disease.","volume":"21","author":"Laforet","year":"2001","journal-title":"J. Neurosci."},{"key":"B114","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nature12517","article-title":"Cerebral organoids model human brain development and microcephaly.","volume":"501","author":"Lancaster","year":"2013","journal-title":"Nature"},{"key":"B115","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/0022-510x(76)90114-90113","article-title":"Morphometric studies of the neuropathological changes in choreatic diseases.","volume":"28","author":"Lange","year":"1976","journal-title":"J. Neurol. Sci."},{"key":"B116","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nn.4256","article-title":"Integrated genomics and proteomics define huntingtin CAG length\u2013dependent networks in mice.","volume":"19","author":"Langfelder","year":"2016","journal-title":"Nat. Neurosci."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1093\/brain\/119.5.1633","article-title":"Executive and mnemonic functions in early Huntington\u2019s disease.","volume":"119","author":"Lawrence","year":"1996","journal-title":"Brain J. Neurol."},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2017.02.033","article-title":"Parvalbumin interneurons modulate striatal output and enhance performance during associative learning.","volume":"93","author":"Lee","year":"2017","journal-title":"Neuron"},{"key":"B119","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1006\/nbdi.2001.0430","article-title":"Impaired glutamate uptake in the R6 Huntington\u2019s disease transgenic mice.","volume":"8","author":"Li\u00e9vens","year":"2001","journal-title":"Neurobiol. Dis."},{"key":"B120","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-81360","article-title":"Exon 1 of the HD Gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"B121","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.parkreldis.2016.02.008","article-title":"Neuropsychiatric symptoms are very common in premanifest and early stage Huntington\u2019s disease.","volume":"25","author":"Martinez-Horta","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2017.11.012","article-title":"Endocannabinoid actions on cortical terminals orchestrate local modulation of dopamine release in the nucleus accumbens.","volume":"96","author":"Mateo","year":"2017","journal-title":"Neuron"},{"key":"B123","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.nbd.2016.08.015","article-title":"Symptom heterogeneity in Huntington\u2019s disease correlates with neuronal degeneration in the cerebral cortex.","volume":"96","author":"Mehrabi","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0049838","article-title":"Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington\u2019s disease: zQ175.","volume":"7","author":"Menalled","year":"2012","journal-title":"PLoS One"},{"key":"B125","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/cne.10776","article-title":"Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington\u2019s disease with 140 CAG repeats.","volume":"465","author":"Menalled","year":"2003","journal-title":"J. Comp. Neurol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"8266","DOI":"10.1523\/jneurosci.22-18-08266.2002","article-title":"Early motor dysfunction and striosomal distribution of huntingtin microaggregates in Huntington\u2019s disease knock-in mice.","volume":"22","author":"Menalled","year":"2002","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1002\/glia.23022","article-title":"Astrocytes are key but indirect contributors to the development of the symptomatology and pathophysiology of Huntington\u2019s disease: astrocytes in Huntington\u2019s disease.","volume":"64","author":"Meunier","year":"2016","journal-title":"Glia"},{"key":"B128","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.nbd.2011.03.006","article-title":"Worsening of Huntington disease phenotype in CB1 receptor knockout mice.","volume":"42","author":"Mievis","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"B129","doi-asserted-by":"publisher","first-page":"735","DOI":"10.2217\/fnl.10.41","article-title":"Corticostriatal circuit dysfunction in Huntington\u2019s disease: intersection of glutamate, dopamine and calcium.","volume":"5","author":"Miller","year":"2010","journal-title":"Future Neurol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.neuroscience.2008.02.004","article-title":"Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington\u2019s disease phenotype in the R6\/2 mouse.","volume":"153","author":"Miller","year":"","journal-title":"Neuroscience"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.3389\/fnsys.2011.00026","article-title":"Dysregulated neuronal activity patterns implicate corticostriatal circuit dysfunction in multiple rodent models of Huntington\u2019s disease.","volume":"5","author":"Miller","year":"2011","journal-title":"Front. Syst. Neurosci."},{"key":"B132","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.nbd.2009.09.013","article-title":"Dysregulation of coordinated neuronal firing patterns in striatum of freely behaving transgenic rats that model Huntington\u2019s disease.","volume":"37","author":"Miller","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"B133","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1152\/jn.90606.2008","article-title":"Dysregulated information processing by medium spiny neurons in striatum of freely behaving mouse models of Huntington\u2019s disease.","volume":"100","author":"Miller","year":"","journal-title":"J. Neurophysiol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuron.2010.01.008","article-title":"Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington\u2019s disease mice.","volume":"65","author":"Milnerwood","year":"2010","journal-title":"Neuron"},{"key":"B135","doi-asserted-by":"publisher","first-page":"12997","DOI":"10.1523\/JNEUROSCI.5284-12.2013","article-title":"Dendritic Spine instability leads to progressive neocortical spine loss in a mouse model of Huntington\u2019s disease.","volume":"33","author":"Murmu","year":"2013","journal-title":"J. Neurosci."},{"key":"B136","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1523\/JNEUROSCI.0244-14.2015","article-title":"Altered sensory experience exacerbates stable Dendritic Spine and synapse loss in a mouse model of Huntington\u2019s disease.","volume":"35","author":"Murmu","year":"2015","journal-title":"J. Neurosci."},{"key":"B137","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/s0168-0102(02)00027-25","article-title":"Functional significance of the cortico-subthalamo-pallidal \u201chyperdirect\u201d pathway.","volume":"43","author":"Nambu","year":"2002","journal-title":"Neurosci. Res."},{"key":"B138","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.clinph.2007.01.009","article-title":"Abnormal intracortical facilitation in early-stage Huntington\u2019s disease.","volume":"118","author":"Nardone","year":"2007","journal-title":"Clin. Neurophysiol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.nbd.2014.08.009","article-title":"Genetic rescue of CB1 receptors on medium spiny neurons prevents loss of excitatory striatal synapses but not motor impairment in HD mice.","volume":"71","author":"Naydenov","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1523\/ENEURO.0210-18.2018","article-title":"Cortico-striatal cross-frequency coupling and gamma genesis disruptions in Huntington\u2019s disease mouse and computational models.","volume":"5","author":"Naze","year":"2018","journal-title":"eNeuro"},{"key":"B141","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.nbd.2010.07.014","article-title":"Cerebral cortex structure in prodromal Huntington disease.","volume":"40","author":"Nopoulos","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"B142","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/nm.2056","article-title":"Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin.","volume":"15","author":"Okamoto","year":"2009","journal-title":"Nat. Med."},{"key":"B143","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/ana.410260103","article-title":"A quantitative investigation of the substantia nigra in Huntington\u2019s disease.","volume":"26","author":"Oyanagi","year":"1989","journal-title":"Ann. Neurol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.nbd.2017.07.020","article-title":"Differential electrophysiological and morphological alterations of thalamostriatal and corticostriatal projections in the R6\/2 mouse model of Huntington\u2019s disease.","volume":"108","author":"Parievsky","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"B145","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41586-018-0090-96","article-title":"Diametric neural ensemble dynamics in parkinsonian and dyskinetic states.","volume":"557","author":"Parker","year":"2018","journal-title":"Nature"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11251","article-title":"Real-time imaging of glutamate clearance reveals normal striatal uptake in Huntington disease mouse models.","volume":"7","author":"Parsons","year":"2016","journal-title":"Nat. Commun."},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1101\/703710","article-title":"Striatal activity reflects cortical activity patterns.","author":"Peters","year":"2019","journal-title":"bioRxiv"},{"key":"B148","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1006\/nbdi.2002.0534","article-title":"Evidence for dysfunction of the nigrostriatal pathway in the R6\/1 line of transgenic Huntington\u2019s disease mice.","volume":"11","author":"Peters\u00e9n","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"B149","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/nn.3446","article-title":"Inhibition of inhibition in visual cortex: the logic of connections between molecularly distinct interneurons.","volume":"16","author":"Pfeffer","year":"2013","journal-title":"Nat. Neurosci."},{"key":"B150","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.bbr.2015.09.030","article-title":"Cortical inhibitory deficits in premanifest and early Huntington\u2019s disease.","volume":"296","author":"Philpott","year":"2016","journal-title":"Behav. Brain Res."},{"key":"B151","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1177\/1073858418807887","article-title":"Thinking outside the box (and Arrow): current themes in Striatal dysfunction in movement disorders.","volume":"25","author":"Plotkin","year":"2018","journal-title":"Neuroscientist"},{"key":"B152","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.conb.2015.01.020","article-title":"Corticostriatal synaptic adaptations in Huntington\u2019s disease.","volume":"33","author":"Plotkin","year":"2015","journal-title":"Curr. Opin. Neurobiol."},{"key":"B153","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/nrn3570","article-title":"Choosing an animal model for the study of Huntington\u2019s disease.","volume":"14","author":"Pouladi","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"B154","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1093\/hmg\/dds037","article-title":"Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice.","volume":"21","author":"Pouladi","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"B155","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3233\/JHD-160221","article-title":"Dysregulation of corticostriatal connectivity in Huntington\u2019s disease: a role for dopamine modulation.","volume":"5","author":"Rangel-Barajas","year":"2016","journal-title":"J. Huntingt. Dis."},{"key":"B156","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-61779-452-0_1","article-title":"Astrocytes: multitalented stars of the central nervous system.","volume":"814","author":"Ransom","year":"2012","journal-title":"Methods Mol. Biol. Clifton NJ"},{"key":"B157","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.neuroscience.2011.08.052","article-title":"Pathophysiology of Huntington\u2019s disease: time-dependent alterations in synaptic and receptor function.","volume":"198","author":"Raymond","year":"2011","journal-title":"Neuroscience"},{"key":"B158","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1002\/ana.20121","article-title":"Functional brain changes in presymptomatic Huntington\u2019s disease.","volume":"55","author":"Reading","year":"2004","journal-title":"Ann. Neurol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/cns.12828","article-title":"Corticostriatal network dysfunction in Huntington\u2019s disease: deficits in neural processing, glutamate transport, and ascorbate release.","volume":"24","author":"Rebec","year":"2018","journal-title":"CNS Neurosci. Ther."},{"key":"B160","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.neuroscience.2005.08.062","article-title":"Hyperactive striatal neurons in symptomatic Huntington R6\/2 mice: variations with behavioral state and repeated ascorbate treatment.","volume":"137","author":"Rebec","year":"2006","journal-title":"Neuroscience"},{"key":"B161","doi-asserted-by":"publisher","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","article-title":"Differential loss of striatal projection neurons in Huntington disease.","volume":"85","author":"Reiner","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B162","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/cns.12844","article-title":"Disrupted striatal neuron inputs and outputs in Huntington\u2019s disease.","volume":"24","author":"Reiner","year":"2018","journal-title":"CNS Neurosci. Ther."},{"key":"B163","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1002\/mds.25624","article-title":"Striatal parvalbuminergic neurons are lost in Huntington\u2019s disease: implications for dystonia.","volume":"28","author":"Reiner","year":"2013","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"B164","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3233\/JHD-120039","article-title":"Antidepressant-Like effect of the norepinephrine-dopamine reuptake inhibitor bupropion in a mouse model of Huntington\u2019s disease with dopaminergic dysfunction.","volume":"1","author":"Renoir","year":"2012","journal-title":"J. Huntingt. Dis."},{"key":"B165","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0304-3940(91)90448-90443","article-title":"Heterogeneous dopamine receptor changes in early and late Huntington\u2019s disease.","volume":"132","author":"Richfield","year":"1991","journal-title":"Neurosci. Lett."},{"key":"B166","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1172-5-40","article-title":"Huntington\u2019s disease: a clinical review.","volume":"5","author":"Roos","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000174432.87383.87","article-title":"Regional cortical thinning in preclinical Huntington disease and its relationship to cognition.","volume":"65","author":"Rosas","year":"2005","journal-title":"Neurology"},{"key":"B168","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1093\/brain\/awn025","article-title":"Cerebral cortex and the clinical expression of Huntington\u2019s disease: complexity and heterogeneity.","volume":"131","author":"Rosas","year":"2008","journal-title":"Brain"},{"key":"B169","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","article-title":"Huntington disease: natural history, biomarkers and prospects for therapeutics.","volume":"10","author":"Ross","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"B170","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.neuroscience.2015.10.039","article-title":"Pathological gamma oscillations, impaired dopamine release, synapse loss and reduced dynamic range of unitary glutamatergic synaptic transmission in the striatum of hypokinetic Q175 Huntington mice.","volume":"311","author":"Rothe","year":"2015","journal-title":"Neuroscience"},{"key":"B171","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/cercor\/bhx285","article-title":"Pathway-specific control of striatal neuron vulnerability by corticostriatal cannabinoid CB1 receptors.","volume":"28","author":"Ruiz-Calvo","year":"2018","journal-title":"Cereb. Cortex"},{"key":"B172","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.biopsych.2008.12.026","article-title":"Abnormal motor cortex excitability in preclinical and very early Huntington\u2019s disease.","volume":"65","author":"Schippling","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"B173","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1523\/JNEUROSCI.1739-17.2017","article-title":"Endocannabinoid-specific impairment in synaptic plasticity in striatum of Huntington\u2019s disease mouse model.","volume":"38","author":"Sepers","year":"2018","journal-title":"J. Neurosci."},{"key":"B174","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1083\/jcb.200508072","article-title":"Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity.","volume":"171","author":"Shin","year":"2005","journal-title":"J. Cell Biol."},{"key":"B175","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.neuron.2012.05.024","article-title":"Network organization of the huntingtin proteomic interactome in mammalian brain.","volume":"75","author":"Shirasaki","year":"2012","journal-title":"Neuron"},{"key":"B176","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1016\/j.celrep.2018.04.052","article-title":"Integrative characterization of the R6\/2 mouse model of Huntington\u2019s disease reveals dysfunctional astrocyte metabolism.","volume":"23","author":"Skotte","year":"2018","journal-title":"Cell Rep."},{"key":"B177","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1162\/jocn_a_01011","article-title":"Differential contributions of Ventral and Dorsal Striatum to early and late phases of cognitive set reconfiguration.","volume":"28","author":"Sleezer","year":"2016","journal-title":"J. Cogn. Neurosci."},{"key":"B178","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease.","volume":"12","author":"Slow","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"B179","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/jnc.14723","article-title":"Alterations in synaptic function and plasticity in Huntington disease.","volume":"150","author":"Smith-Dijak","year":"2019","journal-title":"J. Neurochem."},{"key":"B180","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.neuroscience.2008.09.020","article-title":"Progressive synaptic pathology of motor cortical neurons in a BAC transgenic mouse model of Huntington\u2019s disease.","volume":"157","author":"Spampanato","year":"2008","journal-title":"Neuroscience"},{"key":"B181","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1523\/JNEUROSCI.1658-03.2004","article-title":"Environmental enrichment rescues protein deficits in a mouse model of Huntington\u2019s disease, indicating a possible disease mechanism.","volume":"24","author":"Spires","year":"2004","journal-title":"J. Neurosci."},{"key":"B182","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/brain\/103.1.179","article-title":"Neurochemical alterations in Huntington\u2019s chorea: a study of post-mortem brain tissue.","volume":"103","author":"Spokes","year":"1980","journal-title":"Brain"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.3389\/fnsys.2011.00047","article-title":"Functional changes in neocortical activity in Huntington\u2019s disease model mice: an in vivo intracellular study.","volume":"5","author":"Stern","year":"2011","journal-title":"Front. Syst. Neurosci."},{"key":"B184","doi-asserted-by":"publisher","first-page":"11758","DOI":"10.1523\/JNEUROSCI.2461-07.2007","article-title":"Expression profiling of Huntington\u2019s disease models suggests that brain-derived neurotrophic factor depletion plays a major role in striatal degeneration.","volume":"27","author":"Strand","year":"2007","journal-title":"J. Neurosci."},{"key":"B185","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.neuron.2016.09.007","article-title":"Principles of synaptic organization of GABAergic interneurons in the striatum.","volume":"92","author":"Straub","year":"2016","journal-title":"Neuron"},{"key":"B186","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/syn.1089","article-title":"Vesicular neurotransmitter transporters in Huntington\u2019s disease: Initial observations and comparison with traditional synaptic markers.","volume":"41","author":"Suzuki","year":"2001","journal-title":"Synapse"},{"key":"B187","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S1474-4422(13)70088-70087","article-title":"Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington\u2019s disease in the TRACK-HD study: analysis of 36-month observational data.","volume":"12","author":"Tabrizi","year":"2013","journal-title":"Lancet Neurol."},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.3389\/fnsys.2016.00102","article-title":"Cholinergic interneurons amplify corticostriatal synaptic responses in the Q175 model of Huntington\u2019s disease.","volume":"10","author":"Tanimura","year":"2016","journal-title":"Front. Syst. Neurosci."},{"key":"B189","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nn.4216","article-title":"Adult mouse cortical cell taxonomy revealed by single cell transcriptomics.","volume":"19","author":"Tasic","year":"2016","journal-title":"Nat. Neurosci."},{"key":"B190","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41586-018-0654-655","article-title":"Shared and distinct transcriptomic cell types across neocortical areas.","volume":"563","author":"Tasic","year":"2018","journal-title":"Nature"},{"key":"B191","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes.","volume":"72","year":"1993","journal-title":"Cell"},{"key":"B192","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1093\/brain\/awq047","article-title":"Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington\u2019s disease.","volume":"133","author":"Thu","year":"2010","journal-title":"Brain"},{"key":"B193","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/nn.3691","article-title":"Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington\u2019s disease model mice.","volume":"17","author":"Tong","year":"2014","journal-title":"Nat. Neurosci."},{"key":"B194","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.neuron.2016.06.033","article-title":"GABAergic interneurons in the neocortex: from cellular properties to circuits.","volume":"91","author":"Tremblay","year":"2016","journal-title":"Neuron"},{"key":"B195","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.neuron.2012.09.023","article-title":"Dopaminergic Modulation of Synaptic Transmission in Cortex and Striatum.","volume":"76","author":"Tritsch","year":"2012","journal-title":"Neuron"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14304","article-title":"Dysfunction of ventrolateral striatal dopamine receptor type 2-expressing medium spiny neurons impairs instrumental motivation.","volume":"8","author":"Tsutsui-Kimura","year":"2017","journal-title":"Nat. Commun."},{"key":"B197","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.neulet.2012.02.095","article-title":"Impaired cortico-striatal functional connectivity in prodromal Huntington\u2019s Disease.","volume":"514","author":"Unschuld","year":"2012","journal-title":"Neurosci. Lett."},{"key":"B198","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.2967\/jnumed.110.077156","article-title":"Widespread decrease of type 1 cannabinoid receptor availability in Huntington disease in vivo.","volume":"51","author":"Van Laere","year":"2010","journal-title":"J. Nucl. Med. Off. Publ. Soc. Nucl. Med."},{"key":"B199","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1038\/nn.4562","article-title":"Cortical gamma band synchronization through somatostatin interneurons.","volume":"20","author":"Veit","year":"2017","journal-title":"Nat. Neurosci."},{"key":"B200","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.conb.2017.10.019","article-title":"Molecular insights into cortico-striatal miscommunications in Huntington\u2019s disease.","volume":"48","author":"Veldman","year":"2018","journal-title":"Curr. Opin. Neurobiol."},{"key":"B201","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41593-018-0075-77","article-title":"Striatal neurons directly converted from Huntington\u2019s disease patient fibroblasts recapitulate age-associated disease phenotypes.","volume":"21","author":"Victor","year":"2018","journal-title":"Nat. Neurosci."},{"key":"B202","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.celrep.2017.12.013","article-title":"Reconstituting corticostriatal network on-a-chip reveals the contribution of the presynaptic compartment to Huntington\u2019s disease.","volume":"22","author":"Virlogeux","year":"2018","journal-title":"Cell Rep."},{"key":"B203","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/7854_2014_354","article-title":"The neuropathology of huntington\u2019s disease","author":"Waldvogel","year":"2015","journal-title":"Behavioral Neurobiology of Huntington\u2019s Disease and Parkinson\u2019s Disease Current Topics in Behavioral Neurosciences"},{"key":"B204","doi-asserted-by":"publisher","first-page":"8973","DOI":"10.1523\/JNEUROSCI.2804-08.2008","article-title":"Altered information processing in the prefrontal cortex of Huntington\u2019s disease mouse models.","volume":"28","author":"Walker","year":"2008","journal-title":"J. Neurosci."},{"key":"B205","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.nbd.2011.04.009","article-title":"Reduced expression of conditioned fear in the R6\/2 mouse model of Huntington\u2019s disease is related to abnormal activity in prelimbic cortex.","volume":"43","author":"Walker","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"B206","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1113\/jphysiol.2004.073353","article-title":"Anatomical, physiological and molecular properties of martinotti cells in the somatosensory cortex of the juvenile rat: martinotti cells in somatosensory cortex.","volume":"561","author":"Wang","year":"2004","journal-title":"J. Physiol."},{"key":"B207","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/ana.410400110","article-title":"Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington\u2019s disease.","volume":"40","author":"Weeks","year":"1996","journal-title":"Ann. Neurol."},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.01174","article-title":"Circuit mechanisms of neurodegenerative diseases: a new frontier with miniature fluorescence microscopy.","volume":"13","author":"Werner","year":"2019","journal-title":"Front. Neurosci."},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-34883-w","article-title":"Decreased BDNF release in cortical neurons of a knock-in mouse model of Huntington\u2019s disease.","volume":"8","author":"Yu","year":"2018","journal-title":"Sci. Rep."},{"key":"B210","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1126\/science.aaa1934","article-title":"Brain structure. Cell types in the mouse cortex and hippocampus revealed by single-cell RNA-seq.","volume":"347","author":"Zeisel","year":"2015","journal-title":"Science"},{"key":"B211","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1126\/science.1059581","article-title":"Loss of huntingtin-mediated BDNF Gene Transcription in Huntington\u2019s disease.","volume":"293","author":"Zuccato","year":"2001","journal-title":"Science"},{"key":"B212","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.phrs.2005.01.001","article-title":"Progressive loss of BDNF in a mouse model of Huntington\u2019s disease and rescue by BDNF delivery.","volume":"52","author":"Zuccato","year":"2005","journal-title":"Pharmacol. Res."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2020.00082\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T04:33:04Z","timestamp":1580963584000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2020.00082\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,6]]},"references-count":212,"alternative-id":["10.3389\/fnins.2020.00082"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2020.00082","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,6]]},"article-number":"82"}}